Newsletter Signup | Community
Chemotherapy, biomarker testing and precision cancer medicines and immunotherapy are used to treat stage IIIB-IV NSCLC.
Surgery, radiation, and systemic therapies are all used to treat stage IIIA NSCLC.
The c-Met inhibitor Capmatinib is a promising novel precision cancer medicine for the treatment of EGFR + NSCLC.
Lung cancer is occurring more frequently in women: understand the causes and what can you do to lower your risk.
The WHO classifies air pollution as a carcinogen & ample evidence is emerging on it overall negative health consequences
Tecentriq® Improves NSCLC survival when combined with Avastin & chemotherapy Regardless of PD-L1 Status.
HER 2 + Lung Cancer Treatment?
High incidence of ROS 1 false negative tests reported by U Colorado researchers.
Dana Farber and MDACC discover why anti-PD 1 immunotherapy doesnt work in some patients and work to overcome the…